Unjha Formulations Ltd. benchmarking: Perfomance to industry peers

Financial

	Unjha Formulations	Colinz Laboratories	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	10.34 %	4.71 %	-1068.03 %
5yr average Equity Multiplier	1.62	1.29	29.23
5yr Average Asset Turnover Ratio	3.51	0.64	1.05
5yr Avg Net Profit Margin	1.88 %	5.84 %	-11.29 %
Price to Book	2.53	1.11	0.0
P/E	10.91	23.16	0.0
5yr Avg Cash Conversion Cycle	18.8 Days	-11.59 Days	-92.25 Days
Inventory Days	28.57 Days	56.66 Days	69.37 Days
Days Receivable	41.04 Days	42.5 Days	20.01 Days
Days Payable	53.92 Days	89.1 Days	296.94 Days
5yr Average Interest Coverage Ratio	17.56	11.55	-0.77
5yr Avg ROCE	19.44 %	6.71 %	-14.3 %
5yr Avg Operating Profit Margin	3.19 %	7.54 %	2.43 %
5 yr average Debt to Equity	0.0	0.07	10.96
5yr CAGR Net Profit	32.6 %	18.95 %	n/a
5yr Average Return on Assets	6.62 %	3.68 %	-9.05 %
Shareholdings
Promoter Holding	36.92 %	66.0 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.07 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0